| scholarly article | Q13442814 |
| P2093 | author name string | M A Troester | |
| L A Carey | |||
| A F Olshan | |||
| P G Moorman | |||
| E H Allott | |||
| C-K Tse | |||
| P2860 | cites work | Aspirin intake and survival after breast cancer | Q24604280 |
| Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis | Q24796323 | ||
| Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk | Q28168742 | ||
| Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status | Q28176257 | ||
| Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited | Q28181502 | ||
| Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial | Q28182721 | ||
| Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort | Q28213690 | ||
| Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial | Q28217835 | ||
| Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings | Q28218969 | ||
| Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort | Q28219482 | ||
| Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention | Q29620087 | ||
| Medical comorbidities predict mortality in women with a history of early stage breast cancer | Q33956785 | ||
| Eicosanoids and cancer | Q33966203 | ||
| Aspirin and cancer risk: a quantitative review to 2011. | Q34269637 | ||
| Cyclooxygenase-2: a target for the prevention and treatment of breast cancer | Q34277077 | ||
| Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study | Q34381496 | ||
| Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study | Q34530802 | ||
| Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors | Q34778824 | ||
| Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. | Q35227086 | ||
| Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis | Q35661228 | ||
| Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression | Q35735316 | ||
| Phase II trial of neoadjuvant exemestane in combination with celecoxib in postmenopausal women who have breast cancer. | Q36230831 | ||
| Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial | Q36494133 | ||
| Breast cancer and NSAID use: a meta-analysis | Q36622959 | ||
| Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study | Q36678729 | ||
| Aspirin use and breast cancer risk: a meta-analysis | Q39710075 | ||
| Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis | Q40038248 | ||
| Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast | Q40534891 | ||
| Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer | Q43437945 | ||
| NSAID use and survival after breast cancer diagnosis in post-menopausal women. | Q45143526 | ||
| Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer | Q46565903 | ||
| Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women | Q46694709 | ||
| The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. | Q52337191 | ||
| Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene | Q71826297 | ||
| Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice | Q73693790 | ||
| Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer | Q74376052 | ||
| Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer | Q77601963 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 415-421 | |
| P577 | publication date | 2014-08-24 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study | |
| P478 | volume | 147 |
| Q37580120 | A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer |
| Q44586148 | Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis. |
| Q33687606 | NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis |
| Q26786829 | Obesity and cancer: mechanistic insights from transdisciplinary studies |
Search more.